Shingo Matsumoto, Toru Kondo, Mingming Yang, Ross T Campbell, Kieran F Docherty, Rudolf A de Boer, Akshay S Desai, Carolyn S P Lam, Milton Packer, Bertram Pitt, Jean L Rouleau, Muthiah Vaduganathan, Faiez Zannad, Michael R Zile, Scott D Solomon, Pardeep S Jhund, John J V McMurray
AIMS: Patients with heart failure (HF) and mildly reduced ejection fraction (HFmrEF) and preserved ejection fraction (HFpEF) are often treated with calcium channel blockers (CCBs), although the safety of CCBs in these patients is uncertain. We aimed to investigate the association between CCB use and clinical outcomes in patients with HFmrEF/HFpEF; CCBs were examined overall, as well as by subtype (dihydropyridine and non-dihydropyridine). METHODS AND RESULTS: We pooled individual patient data from four large HFpEF/HFmrEF trials...
September 28, 2023: European Journal of Heart Failure